Log In
Print
BCIQ
Print
Print this Print this
 

HPV-SLP (ISA-HPV-01, ISA101, SLP-HPV-01)

  Manage Alerts
Collapse Summary General Information
Company ISA Pharmaceuticals B.V.
DescriptionVaccine consisting of nine HPV 16 E6 and four HPV 16 E7 synthetic peptides
Molecular Target E6 transforming protein (Human papillomavirus-16) (HpV16gp1) ; E7 transforming protein (Human papillomavirus-16) (HpV16gp2)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today